KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Equity (2018 - 2025)

Castle Biosciences' Return on Equity history spans 7 years, with the latest figure at 0.05% for Q4 2025.

  • For Q4 2025, Return on Equity fell 9.0% year-over-year to 0.05%; the TTM value through Dec 2025 reached 0.05%, down 9.0%, while the annual FY2025 figure was 0.05%, 10.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.05% at Castle Biosciences, down from 0.03% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.04% in Q4 2024 and bottomed at 0.23% in Q2 2023.
  • The 5-year median for Return on Equity is 0.07% (2021), against an average of 0.09%.
  • The largest annual shift saw Return on Equity dropped -12bps in 2021 before it increased 23bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.09% in 2021, then tumbled by -78bps to 0.17% in 2022, then grew by 11bps to 0.15% in 2023, then surged by 128bps to 0.04% in 2024, then crashed by -227bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Return on Equity are 0.05% (Q4 2025), 0.03% (Q3 2025), and 0.02% (Q2 2025).